Clinical trial to evaluate the efficacy of botulinum toxin type A injection for reducing scars in patients with forehead laceration: A double-blinded, randomized controlled study

BACKGROUND: Botulinum toxin type A (BoNTA) is known to prevent fibroblast proliferation and expression of transforming growth factor beta 1 (TGF-β1). It also induces temporary muscle paralysis and decreases tension vectors. Fibroblasts induce scar contracture and hypertrophy by producing collagen fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seong Hwan, Lee, Seong Joo, Lee, Jun Won, Jeong, Hii Sun, Suh, In Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716761/
https://www.ncbi.nlm.nih.gov/pubmed/31441893
http://dx.doi.org/10.1097/MD.0000000000016952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716761/
https://www.ncbi.nlm.nih.gov/pubmed/31441893
http://dx.doi.org/10.1097/MD.0000000000016952

Ejemplares similares